PCV39 - ASSESSMENT OF THE BUDGET IMPACT OF INTRAVENOUS FERRIC CARBOXYMALTOSE (FCM) FOR TREATING IRON DEFICIENCY ANEMIA IN CONGESTIVE HEART FAILURE PATIENTS IN GREECE

Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.586
https://www.valueinhealthjournal.com/article/S1098-3015(18)33886-5/fulltext
Title : PCV39 - ASSESSMENT OF THE BUDGET IMPACT OF INTRAVENOUS FERRIC CARBOXYMALTOSE (FCM) FOR TREATING IRON DEFICIENCY ANEMIA IN CONGESTIVE HEART FAILURE PATIENTS IN GREECE
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33886-5&doi=10.1016/j.jval.2018.09.586
First page :
Section Title :
Open access? : No
Section Order : 2478
Categories :
Tags :
Regions :
ViH Article Tags :